期刊文献+

依诺肝素钠的制备与纯化 被引量:9

Preparation and Purification of Enoxaparin Sodium
下载PDF
导出
摘要 以肝素钠为原料,经成盐、酯化、解聚和纯化得到依诺肝素钠。研究了影响酯化率与成环率的主要因素,控制合适的酯化、解聚和纯化条件,得到的依诺肝素钠成品符合欧洲药典标准。 Enoxaparin sodium was prepared from heparin sodium via salinization, esterification, depolymerization and purification. Major factors that affected the degree of esterification and 1,6-anhydro ring formation were studied to produce the title compound which met the European Pharmacopoeia standard.
出处 《中国医药工业杂志》 CAS CSCD 北大核心 2008年第1期15-17,共3页 Chinese Journal of Pharmaceuticals
关键词 肝素钠 酯化 依诺肝素钠 大孔吸附树脂 heparin sodium esterification enoxaparin sodium macroporous resin
  • 相关文献

参考文献4

  • 1石峰,姬胜利,迟延青,张天民.低分子肝素的制备方法及其结构与生物活性的关系[J].中国生化药物杂志,2003,24(2):101-104. 被引量:27
  • 2Rieux RD. Mixtures of particular LMWH heparinic polysacchrides for the prophylaxis/treatment of acute thrombotic events: US, 5389618 [P]. 1995-02-14; DE, 4121115 [P]. 1992-01-02. (CA1992, 116: 108670)
  • 3Mardiguian JS. Heparin esters and processes for their preparation: US, 4440926 [P]. 1984-04-03; FR, 2482603 [P]. 1981-11-20. (CA1982, 96: 205388)
  • 4Bianchini P, Mascellani G. Few bicyclic acetals at reducing end of low-molecular-weight heparins: might they restrict specification of pharmacopoeia [J], Pharmeur Sci Notes, 2005, (1): 1-3.

二级参考文献19

  • 1王福清,张天民,崔慧斐,许荔新.低抗凝肝素来源低分子肝素的研制及药代动力学[J].中国药学杂志,1994,29(2):99-101. 被引量:4
  • 2曹跃琼,陶元器,杨春雷.肝素中存在的一个不易被亚硝酸降解的片段[J].中国生化药物杂志,1996,17(1):1-4. 被引量:3
  • 3姬胜利,张天民.肝素与低分子肝素的研究进展[J].中国生化药物杂志,1996,17(5):216-219. 被引量:33
  • 4Lormean JC, Maine M J, Choay J. Oligosacehacides having anti-Xa activity and pharmaceutical composition containing them [ P ]. US4401662, 1983.
  • 5Smith MR. Process for manufacturing low molecular weight heparins by depolymerization of normal heparin [P]. EP 0101041, 1983.
  • 6Yasuo H. Production of low molecular weight heparin [P ]. JP11130801, 1999.
  • 7Linhardt RJ. Analysis of glycosaminoglycans with polysaccharldelyases( Vol 2) [M]. New York: Wiley Interscience: 1994.17-32.
  • 8Fareed J, Jeske W, Hoppensteadt D, et al. Low molecular weight heparins : Pharmceutical profile and product differentiation[J]. Am J Cardiol, 1998, 82 : 3-10.
  • 9Linhardt RJ, Loganathan D, M-Hakim et al. Oligosaccharide mapping of low molecular weight heparins : Structure and activity differences [ J].J Med Chem, 1990, 33: 1639-1645.
  • 10Linhardt RJ. Production and chemical processing of low molecular weight heparins[J]. Semi throm hemo, 1999, 25 (suppl 3) : 5-16.

共引文献26

同被引文献87

引证文献9

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部